Gene: ZNF225
Official Full Name: zinc finger protein 225provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34485 | ZNF225 Knockout cell line (HeLa) | Human | ZNF225 | 1:3~1:6 | Negative | Online Inquiry |
KO34486 | ZNF225 Knockout cell line (HCT 116) | Human | ZNF225 | 1:2~1:4 | Negative | Online Inquiry |
KO34487 | ZNF225 Knockout cell line (HEK293) | Human | ZNF225 | 1:3~1:6 | Negative | Online Inquiry |
KO34488 | ZNF225 Knockout cell line (A549) | Human | ZNF225 | 1:3~1:4 | Negative | Online Inquiry |
ZNF225 Gene Knockout Cell Lines are a pioneering resource designed for studying the function of the ZNF225 gene, a member of the zinc finger protein family known to play critical roles in transcriptional regulation and cellular differentiation processes. These cell lines are genetically engineered to exhibit a complete absence of the ZNF225 protein, allowing researchers to investigate the gene's contribution to various biological pathways and disease states more effectively.
The central mechanism underlying these knockout cell lines involves the use of CRISPR/Cas9 technology, which allows for precise gene editing by introducing targeted double-strand breaks in the DNA, facilitating the removal of the ZNF225 gene. This precise deletion capability enhances the reliability and accuracy of functional studies, as it provides a clear model for assessing changes in cellular behavior in the absence of this specific gene.
The scientific significance of ZNF225 Gene Knockout Cell Lines lies in their applications across various fields including oncology, developmental biology, and neurobiology. These models enable researchers to elucidate the pathways involved in cancer progression, the mechanisms of differentiation, and the potential roles of ZNF225 in neurological disorders. The ability to observe these effects in controlled environments enhances our understanding of ZNF225 as a target for therapeutic interventions.
Compared to alternative methods such as siRNA or antisense oligonucleotides, which provide transient knockdown, ZNF225 Gene Knockout Cell Lines offer a stable and permanent modification, leading to reproducible results in long-term studies. Additionally, the persistence of the knockout phenotype ensures that experimental outcomes are less influenced by transient transfection efficiencies or off-target effects, which can confound research results.
For researchers and clinicians aiming to deepen their understanding of gene function, as well as those looking to develop innovative therapeutic strategies, ZNF225 Gene Knockout Cell Lines present an invaluable tool. These cell lines not only streamline research workflows but also provide a robust framework for investigating complex biological systems related to ZNF225.
Our company prides itself on its commitment to advancing molecular biology tools, continuously striving to provide cutting-edge resources that empower researchers in their quest for scientific discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.